Scott Helberg
Pulmonary Disease · Yankton, SDNPI 1619173945
Payments from drug & device makers
$621,269in general payments, 2019–2025
Across 725 payments — averaging $856.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$508K
- GSK$75K
- Amgen$36K
- Johnson & Johnson$1K
- Regeneron Healthcare Solutions, Inc.$97
- Insmed, Inc.$57
- plus $368 from 11 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 539 | $508,412 |
| GSK | 112 | $75,268 |
| Amgen | 34 | $35,631 |
| Johnson & Johnson | 8 | $1,436 |
| Regeneron Healthcare Solutions, Inc. | 4 | $97 |
| Insmed, Inc. | 4 | $57 |
| Merck | 4 | $50 |
| Boehringer Ingelheim | 4 | $50 |
| Baxter Healthcare | 3 | $47 |
| Genentech, Inc. | 1 | $46 |
| Advanced Respiratory, Inc | 3 | $42 |
| Resmed Corp | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| Mylan Specialty L.p. | 2 | $25 |
| Sanofi | 1 | $18 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| United Therapeutics Corporation | 1 | $12 |
How this compares
$621,269 in reported general payments places this provider in the 95th percentile of 35 pulmonary disease providers in South Dakota.
Other pulmonary disease in Yankton
- Michael PietilaYankton$79K
- Lori HansenYankton$10K
- Fady JamousSioux Falls$56K
- Svien SenneWatertown$13K
- Joevasanth DevasahayamSioux Falls$8K
- Matthew TaylorSioux Falls$8K
- Cliff JanikowskiRapid City$6K
- Rizan HajalSioux Falls$5K
- Deptmer AshleyAberdeen$5K
- Kaitlin BranickSioux Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.